Related Experiment Video
Updated: Aug 7, 2026
07:20
Automated Behavioral Analysis of Large C. elegans Populations Using a Wide Field-of-view Tracking Platform
Published on: November 28, 2018
XForms and XML events to support decisions about medication management
Jean-Pierre Calabretto1, Debdeep Banerjee, Jim Warren
1University of South Australia.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|June 17, 2006
Summary
Extensible Markup Language (XML) technologies like XForms and XML events show promise for improving healthcare information presentation and accessibility, particularly in medication management decision support systems. While XForms aids rapid interface prototyping, XML events have limitations, especially with date functionality.
Area of Science:
- Health Informatics
- Computer Science
Background:
- Healthcare information representation faces challenges with common formats and accessibility.
- Existing systems struggle to effectively present and manage complex health data.
Purpose of the Study:
- To investigate the utility of Extensible Markup Language (XML) technologies, specifically XForms and XML events, for enhancing healthcare information presentation.
- To evaluate the application of these technologies in decision support for medication management.
Main Methods:
- Utilized XForms for rapid prototyping of information models and user interfaces.
- Employed XML events to model simple alert functionalities within the healthcare context.
Main Results:
- XForms demonstrated effectiveness in accelerating the development of information models and interfaces.
- XML events proved useful for creating basic alerts, though certain components like date handling presented limitations.
Conclusions:
- XML-based technologies, including XForms and XML events, offer a promising infrastructure for addressing challenges in healthcare information representation and presentation.
- Further development is needed to overcome limitations in components like date functionality for broader application in medication management decision support.
Related Concept Videos
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...